Yunting Zou

Highly Potent, Selective, Biostable, and Cell-Permeable Cyclic <scp>d</scp>-Peptide for Dual-Targeting Therapy of Lung Cancer

Yunjiang Zhou, Yunting Zou, Mei Yang et al. · Journal of the American Chemical Society · 2022 · 59 citations

Discovery of a Dual Tubulin and Poly(ADP-Ribose) Polymerase-1 Inhibitor by Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, and Biological Evaluation

Lufeng Zheng, Ren Ren, Xiaolian Sun et al. · Journal of Medicinal Chemistry · 2021 · 46 citations · Full text

Drug Target, Pathology, Parp-1 Dna +24

Discovery of a Potent Dual Son of Sevenless 1 (SOS1) and Epidermal Growth Factor Receptor (EGFR) Inhibitor for the Treatment of Prostate Cancer

Lufeng Zheng, Yuxin Zhang, Shuang Mei et al. · Journal of Medicinal Chemistry · 2024 · 22 citations · Full text

Discovery of a Dual Tubulin and Neuropilin-1 (NRP1) Inhibitor with Potent In Vivo Anti-Tumor Activity via Pharmacophore-based Docking Screening, Structure Optimization, and Biological Evaluation

Lufeng Zheng, Yunting Zou, Tianyuan Xie et al. · Journal of Medicinal Chemistry · 2023 · 18 citations

Pharmacotherapy, Structure Optimization, Tumor Biology +21

Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation

Yonghua Xu, Yunting Zou, Shasha Zhou et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2023 · 10 citations · Full text